Sleep Medicine Research Group
Humans spend up to one-third of their lives sleeping. Sleep is one of the most basic human needs, along with eating and drinking, and fundamentally affects a person’s overall health. Almost everyone has had a short-term sleep disorder at least once in their lives, and 15–30% of the population suffer from it chronically. Regular breathing during sleep is very important. If breathing is interrupted and stops several times during the night, it is called sleep apnoea and it may lead to complications such as hypertension, ischemic heart disease, stroke, and diabetes. 3–8% of the middle and upper-age population suffer from obstructive sleep apnoea syndrome, of which more are men than women.
The team’s research is focused on studying the significance of the risk factors associated with breathing disorders and their connection to cardiovascular diseases and obesity. Early diagnosis of sleep apnoea could significantly reduce the occurrence of obesity and cardiovascular diseases, which is why an important part of the team’s work is performing an ongoing analysis of the data obtained from projects in which patients are involved. This allows for the better identification of major risk factors and helps with their removal and in prescribing the appropriate therapy. An integral part of this is the development of new technologies that allow for the clarification of the links between the cardiovascular and central nervous systems.